Bristol Myers rises on AstraZeneca merger speculation, but market-cap figures urge restraint

Bristol-Myers Squibb Company gained approximately 8% in premarket trade ahead of the start of regular U.S. trading, following news of initial discussions with AstraZeneca PLC.

AstraZeneca (LON:AZN) falls as news of deal talks wipes out about $5 billion in total value

AstraZeneca shares dropped roughly 5% on Monday following news of early-stage merger discussions. Bristol Myers gained approximately 6% ahead of the New York cash session.

3 August 2026

LON:AZN·Pharmaceuticals·Stock Market

FTSE 100 pares early oil-driven gains in London trade

London stocks were up on Monday, though the bulk of initial gains faded shortly after the open. By 09:40 BST, the FTSE 100 was ahead by 0.27% at 10,765.69, having started the session with a rise of 0.88%.

27 July 2026

LON:AZN·LON:BP·LON:IAG·LON:SHEL·LON:VOD·Stock Market

FTSE 100 Outlook: Oil Results and Bank of England Policy in Focus

Energy could contribute roughly 62% of the anticipated growth in European earnings for the second quarter. With that early estimate, the FTSE 100’s performance this week is more reliant on oil than usual. The resulting oil surge is also pushing up inflation and bond yields.

26 July 2026

Earnings·LON:AZN·LON:BARC·LON:GSK·LON:LSEG·LON:ULVR·LON:VOD·Stock Market